QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor Relations
QuidelOrtho appointed Sanjeev Sharma, CFA, as Vice President of Investor Relations, effective September 28, 2026. Sharma brings 20+ years of experience, most recently as Senior Director of IR at Teva Pharmaceuticals, with prior IR and strategy roles at Genpact and sell-side equity research experience.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.